TSX open
Loading markets…
Stocks/NASDAQ/DXCM

DexCom Inc (DXCM : NASDAQ)

Common Stock

$82.97

USD

-1.79 (-2.11%)

Last updated: 2026-11-03

Follow DXCM

DXCM

DexCom Inc

Source:WealthAwesomeWealthAwesome
↓ $4.76 (-5.43%)
30 day period
$77.94$82.84$87.73Sep 23Oct 14Nov 3

Performance

1 Day

-2.11%

1 Week

+5.61%

1 Month

-2.80%

YTD

+24.69%

Key Statistics

Market Cap

$30.94B

52W High

$92.59

52W Low

$54.11

P/E Ratio

32.67

50 Day MA

$85.67

200 Day MA

$74.64

Beta

1.44

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/3/2026$84.55$85.18$82.81$82.97$82.974,125,017
11/2/2026$82.94$85.19$82.52$84.76$84.764,058,776
10/30/2026$81.52$85.25$79.79$82.29$82.298,637,200
10/29/2026$79.08$80.01$78.59$79.93$79.935,909,294
10/28/2026$78.15$79.41$77.69$78.62$78.625,371,695
10/27/2026$78.58$79.86$78.05$78.56$78.565,159,356
10/26/2026$77.25$78.58$76.52$78.57$78.576,019,297
10/23/2026$78.68$79.51$77.82$77.94$77.945,218,200
10/22/2026$79.90$80.49$77.11$78.32$78.3210,792,711
10/21/2026$83.75$86.17$79.92$80.26$80.268,000,120

Analyst Price Targets

Based on 29 analysts covering DXCM · as of Nov 3, 2026

📈

Wall Street analysts forecast DXCM stock price to rise 18.3% over the next 12 months.

Consensus

Strong Buy

4.66 / 5.00

Avg. Target

US$98.15

+18.3% Upside

Previously US$97.23 on Nov 2, 2026

Current Price

US$82.97

Last close

Analyst Breakdown (29 analysts)

Strong Buy 22
Buy 4
Hold 3
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on DXCM's historical volatility

HistoricalForecast68%95%
US$48.97US$63.00US$77.03US$91.07US$105.10US$119.13TodayJun 29Sep 1Nov 3Dec 16Jan 29Mar 13

30-Day Vol

34.7%

Annualized

90-Day Vol

39.5%

Annualized

Trend (90d)

-23.0%

Annualized drift

90d Mean

US$76.41

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$80.72US$71.62 – US$90.99
60 trading daysUS$78.54US$66.31 – US$93.02
90 trading daysUS$76.41US$62.11 – US$94.01

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Financials

Revenue (TTM)
$5.10B
EBITDA
$1.50B
Profit Margin
19.42%
ROE (TTM)
37.67%
EPS (Diluted)
2.54
Book Value
6.80

Classification

Sector
Health Care
Industry
Health Care Equipment & Supplies
Group
Health Care Equipment & Services

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About DXCM.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
CHSNChanson International Holding Class A Ordinary Shares$3.38+241.24%
RDACRising Dragon Acquisition Corp. Ordinary Shares$11.30+121.57%
MERCMercer International Inc$0.21+68.25%
PARAParabolic Technologies, Inc.$2.72+60.95%
KTTAPasithea Therapeutics Corp$0.53+44.02%
FEEDENvue Medical Inc.$0.35+40.00%
IFBDInfobird Co Ltd$1.43+38.83%
CRMTAmericas Car-Mart Inc$1.21+32.73%

DXCM.US news timeline

11 articles covering DXCM.US, most recent first

Latest

DexCom G7 15 Day System to Launch in Canada in November: What Investors Should Know

•Stocks